Clinical Trial Results
Showing:
All studies
[change]
Condition: Alzheimer's
Location: San Francisco, California
25 trials found
New Search
Characterizing Cognitive Decline in Late Life Depression: The ADNI Depression Project
RECRUITING
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
RECRUITING
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
RECRUITING
[18F]PI-2620 Phase 3 Histopathological Study
RECRUITING
Alzheimer's Tau Platform: Master Protocol
RECRUITING
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING
Remotely-supervised Neuromodulation in PPA
RECRUITING
A Study of Psychedelics in Healthy Older Adults With Low Well-being
RECRUITING
CMN LIFU for Enhanced Glymphatic Clearance in Amyloid-Positive MCI
RECRUITING
A Study of LY3439539 in Participants With Alzheimer's Disease
RECRUITING
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
RECRUITING
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RECRUITING
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
RECRUITING
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
RECRUITING
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RECRUITING
Senicapoc in Alzheimer's Disease
RECRUITING
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
RECRUITING
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
RECRUITING
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
RECRUITING